Brivaracetam
Brand names: BRIVIACT
Therapeutic Indications
Brivaracetam is indicated for:
at least one of
Localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
Complex partial status epilepticus
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
Complex partial status epilepticus
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Oral
Contraindications
Active ingredient Brivaracetam is contraindicated in the following cases: